Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Evaluation of their plasma calcidiol levels showed no significant difference between the S and HFHS groups at W0 or W13 (Figure 2).
Source: 3.5. Plasma Calcidiol Levels. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Animal research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
The rats were divided into two groups (n = 32) and subjected to either a standard diet (S; 3.84 Kcal/g) (3430 Kliba Nafag, Kaiseraugst, Switzerland) or an HFHS diet composed of pellets (4.73 Kcal/g) (D12451 Research Diets®, Lynge, Denmark) and sweetened condensed milk (3.22 Kcal/g) (Nestlé®, Nantes, France) ad libitum ().
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Omega-3 Fatty Acid and Vitamin D Supplementations Partially Reversed Metabolic Disorders and Restored Gut Microbiota in Obese Wistar Rats
Study design awaiting verification · Biology · 2024
Original publication title
Omega-3 Fatty Acid and Vitamin D Supplementations Partially Reversed Metabolic Disorders and Restored Gut Microbiota in Obese Wistar Rats
© 2024 by the authors.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Simple Summary
Obesity is a major health issue affecting both humans and animals, leading to various related health problems. This study explored whether vitamin D and omega-3 fatty acids, alone or together, could help manage obesity and its related disorders in rats. Over the course of 26 weeks, rats were first fed a diet high in fat and sugar to induce obesity. They were then given either vitamin D, omega-3 fatty acids, both together, or no supplement at all. The results showed that vitamin D helped improve their blood sugar levels and reduced liver damage, while omega-3 fatty acids slowed weight gain, reduced fat, and improved gut health.
When used together, these supplements were even more effective in preventing weight gain and improving overall health. These findings suggest that vitamin D and omega-3 fatty acids could be a promising approach to managing obesity and its complications, not only in animals but potentially in humans as well. This research could lead to better strategies for preventing and treating obesity, benefiting public health.
Abstract
Obesity is a global public health issue linked to various comorbidities in both humans and animals. This study investigated the effects of vitamin D (VD) and omega-3 fatty acids (ω3FA) on obesity, gut dysbiosis, and metabolic alterations in Wistar rats. After 13 weeks on a standard (S) or High-Fat, High-Sugar (HFHS) diet, the rats received VD, ω3FA, a combination (VD/ω3), or a control (C) for another 13 weeks. The HFHS diet led to increased weight gain, abdominal circumference, glucose intolerance, insulin resistance, and gut dysbiosis.
VD supplementation improved their fasting blood glucose and reduced liver damage, while ω3FA slowed BMI progression, reduced abdominal fat, liver damage, and intestinal permeability, and modulated the gut microbiota. The combination of VD/ω3 prevented weight gain, decreased abdominal circumference, improved glucose tolerance, and reduced triglycerides. This study demonstrates that VD and ω3FA, alone or combined, offer significant benefits in preventing obesity, gut dysbiosis, and metabolic alterations, with the VD/ω3 combination showing the most promise. Further research is needed to explore the mechanisms behind these effects and their long-term potential in both animal and human obesity management.
Authors’ abstract
Simple Summary
Obesity is a major health issue affecting both humans and animals, leading to various related health problems. This study explored whether vitamin D and omega-3 fatty acids, alone or together, could help manage obesity and its related disorders in rats. Over the course of 26 weeks, rats were first fed a diet high in fat and sugar to induce obesity. They were then given either vitamin D, omega-3 fatty acids, both together, or no supplement at all. The results showed that vitamin D helped improve their blood sugar levels and reduced liver damage, while omega-3 fatty acids slowed weight gain, reduced fat, and improved gut health.
When used together, these supplements were even more effective in preventing weight gain and improving overall health. These findings suggest that vitamin D and omega-3 fatty acids could be a promising approach to managing obesity and its complications, not only in animals but potentially in humans as well. This research could lead to better strategies for preventing and treating obesity, benefiting public health.
Abstract
Obesity is a global public health issue linked to various comorbidities in both humans and animals. This study investigated the effects of vitamin D (VD) and omega-3 fatty acids (ω3FA) on obesity, gut dysbiosis, and metabolic alterations in Wistar rats. After 13 weeks on a standard (S) or High-Fat, High-Sugar (HFHS) diet, the rats received VD, ω3FA, a combination (VD/ω3), or a control (C) for another 13 weeks. The HFHS diet led to increased weight gain, abdominal circumference, glucose intolerance, insulin resistance, and gut dysbiosis.
VD supplementation improved their fasting blood glucose and reduced liver damage, while ω3FA slowed BMI progression, reduced abdominal fat, liver damage, and intestinal permeability, and modulated the gut microbiota. The combination of VD/ω3 prevented weight gain, decreased abdominal circumference, improved glucose tolerance, and reduced triglycerides. This study demonstrates that VD and ω3FA, alone or combined, offer significant benefits in preventing obesity, gut dysbiosis, and metabolic alterations, with the VD/ω3 combination showing the most promise. Further research is needed to explore the mechanisms behind these effects and their long-term potential in both animal and human obesity management.
Publication and source details
Original title: Omega-3 Fatty Acid and Vitamin D Supplementations Partially Reversed Metabolic Disorders and Restored Gut Microbiota in Obese Wistar Rats
Dylan Le Jan; Mohamed Siliman Misha; Sandrine Destrumelle; Olivia Terceve; Chantal Thorin; Thibaut Larcher; Mireille Ledevin; Jean-Claude Desfontis; Eric Betti; Yassine Mallem
Biology · 2024
* Correspondence: dylan.lejan@gmail.com (D.L.J.); yassine.mallem@oniris-nantes.fr (Y.M.)© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).This research received no external funding.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T03:05:44.744592+00:00
DOI: 10.3390/biology13121070 · PMC11673857